Skip to main content

Home/ Business News/ Group items tagged DXCM

Rss Feed Group items tagged

Filter: All | Bookmarks | Topics Simple Middle
Equities Group

Medivation Stock Doubles to Lead Prostate Cancer Biotechs | equities.com - 0 views

editorial.equities.com/...-lead-prostate-cancer-biotechs

equities.com investing Medivation prostate cancer cancer MDVN ALPMY Astellas Pharmaceuticals MDV3100 DNDN Dendreon Corp. JNJ healthcare stocks healthcare Anika Therapeutics ANIK ABIOMED ABMD SonoSite SONO SNT Senesco Technologies Hansen Medical HNSN DXCM

shared by Equities Group on 04 Nov 11 - No Cached
  • Equities Group on 04 Nov 11
     
    Stock in biotech company Medivation more than doubled in value after reports that their phase III study of a new drug to treat prostate cancer has showed major success.
1 - 1 of 1
Showing 20▼ items per page